# Vincent Esnault

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/vincent-esnault/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,183 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 41 |
| i10-index | 100 |
| Last Known Institution | Clinical Trial Investigators |
| OpenAlex ID | https://openalex.org/A5080660015 |
| ORCID iD | 0000-0002-7418-5672 |
| Works | 198 |

## Researcher papers

- [International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)](https://scholariq.org/papers/international-consensus-statement-on-testing-and-reporting-of-antineutrophil/)
- [Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/atrasentan-and-renal-events-in-patients-with-type-2-diabetes-and-chronic-kidney/)
- [KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron](https://scholariq.org/papers/klhl3-mutations-cause-familial-hyperkalemic-hypertension-by-impairing-ion/)
- [A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease](https://scholariq.org/papers/a-clinical-score-to-predict-6-month-prognosis-in-elderly-patients-starting/)
- [Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy](https://scholariq.org/papers/epitope-spreading-of-autoantibody-response-to-pla2r-associates-with-poor/)
- [Alpha1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis](https://scholariq.org/papers/alpha1-antitrypsin-genetic-polymorphism-in-anca-positive-systemic-vasculitis/)
- [High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial](https://scholariq.org/papers/high-dose-furosemide-for-established-arf-a-prospective-randomized-double-blind/)
- [Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial](https://scholariq.org/papers/adherence-to-antihypertensive-treatment-and-the-blood-pressure-lowering-effects/)
- [Visceral fat is associated to the severity of COVID-19](https://scholariq.org/papers/visceral-fat-is-associated-to-the-severity-of-covid-19/)
- [High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy](https://scholariq.org/papers/high-dose-rituximab-and-early-remission-in-pla2r1-related-membranous-nephropathy/)
- [Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis](https://scholariq.org/papers/spironolactone-in-patients-on-chronic-haemodialysis-at-high-risk-of-adverse/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [Clinical Trial Investigators](https://scholariq.org/institutions/clinical-trial-investigators/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.